Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “System; Sclerosis”

5,479 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,479 results

Not applicableLooking for participantsNCT06051123
What this trial is testing

Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients

Who this might be right for
ALSFTDALS (Amyotrophic Lateral Sclerosis)Frontal Temporal Dementia (FTD)
Centre hospitalier de l'Université de Montréal (CHUM) 150
Not applicableWithdrawnNCT03892382
What this trial is testing

Repetitive Transcranial Magnetic Stimulation as Therapy for Apathy in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Jagiellonian University
Not applicableStudy completedNCT03645031
What this trial is testing

Acute Intermittent Hypoxia and Breathing in Neuromuscular Disease

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)Neuromuscular Diseases
University of Florida 29
Not applicableStudy completedNCT04917146
What this trial is testing

Systemic Sclerosis' Relatives Reflex

Who this might be right for
Systemic SclerosisCaregivers
Assistance Publique - Hôpitaux de Paris 50
Not applicableStudy completedNCT03302442
What this trial is testing

Comparison of Oral Molecules Preventing Relapses in Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Nantes University Hospital 3,000
Large-scale testing (Phase 3)Study completedNCT06987851
What this trial is testing

An Extension Clinical Study of the Efficacy and Safety of BCD-132 in Patients With Multiple Sclerosis Who Previously Received Therapy in Clinical Studies of JSC BIOCAD

Who this might be right for
Multiple Sclerosis
Biocad 44
Not applicableStudy completedNCT05746845
What this trial is testing

Implication of 5-HT7 Receptor in Inflammatory Mechanisms in Multiple Sclerosis

Who this might be right for
HealthyMultiple Sclerosis
Centre Hospitalier Régional d'Orléans 100
Large-scale testing (Phase 3)Study completedNCT01874145
What this trial is testing

Safety and Tolerability of Glatiramer Acetate

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 209
Not applicableActive Not RecruitingNCT07028879
What this trial is testing

Effectiveness of a One-year Group Program for Fatigue Management in Minimally Impaired People With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Hospital Clinic of Barcelona 24
Large-scale testing (Phase 3)Study completedNCT00372879
What this trial is testing

Clinical Trial of Vitamin E to Treat Muscular Cramps in Patients With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 32
Not applicableStudy completedNCT03244696
What this trial is testing

Behavior and Activity Monitoring in MS

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Ohio State University 87
Not applicableStudy completedNCT00617383
What this trial is testing

AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MS

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
The University of Texas Health Science Center, Houston 3
Early research (Phase 1)Study completedNCT02583594
What this trial is testing

Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple Sclerosis

Who this might be right for
Progressive Multiple Sclerosis
Genzyme, a Sanofi Company 24
Not applicableUnknownNCT06379646
What this trial is testing

An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease

Who this might be right for
Systemic Lupus ErythematosusSystemic SclerosisInflammatory Myopathy+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 6
Testing effectiveness (Phase 2)Study completedNCT01071083
What this trial is testing

Treatment Interruption of Natalizumab

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Biogen 175
Not applicableLooking for participantsNCT07723872
What this trial is testing

Finger Versus Earlobe Pulse Oximetry During the 6-Minute Walk Test in Interstitial Lung Disease

Who this might be right for
Interstitial Lung Disease (ILD)Idiopathic Pulmonary Fibrosis (IPF)Progressive Pulmonary Fibrosis+2 more
Hospital de Granollers 100
Not applicableLooking for participantsNCT07168772
What this trial is testing

The Effect of a Probiotic Administration as an add-on Treatment in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Hospital Universitari Vall d'Hebron Research Institute 80
Not applicableUnknownNCT06566651
What this trial is testing

Emotion Processing Among Patients With ALS

Who this might be right for
Amyotrophic Lateral SclerosisNeuromuscular DiseasesALS+2 more
University of Aarhus 180
Large-scale testing (Phase 3)Active Not RecruitingNCT04768972
What this trial is testing

FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Ionis Pharmaceuticals, Inc. 89
Not applicableUnknownNCT03817073
What this trial is testing

Assessing Fatiguability of Tongue Muscles in MS

Who this might be right for
Muscle WeaknessFatigueMultiple Sclerosis+2 more
Thomas More Kempen 60
Next Page